Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senators Seek “Fresh” Ideas To Fight Health Fraud From Stakeholders

This article was originally published in The Pink Sheet Daily

Executive Summary

An open letter to the “health care community” from a bipartisan group of senators on the Finance Committee asks for white papers offering suggestions on the best ways to combat “the multi-billion dollar problem” of waste, fraud and abuse in Medicare and Medicaid.

You may also be interested in...



HHS OIG To Investigate Drug Shortages, Rebates, Other Pharma Issues In 2013

A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.

McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement

Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.

CMS Adopts Trial-Size Prescriptions For Part D, Delays Implementation

CMS mandates that Part D plans offer prescriptions filled for less than a 30-day period at a daily cost-sharing rate, with a few stated exceptions, but delays implementation until the 2014 plan year.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel